logo
Swiss Village Devastated By Glacier Collapse

Swiss Village Devastated By Glacier Collapse

Yahoo5 days ago

A massive landslide triggered by the collapse of a glacier buried much of the Alpine village of Blatten in Switzerland's Lötschental valley on Wednesday, destroying 90% of the town and leaving a 64-year-old man missing, authorities said.
Search-and-rescue efforts were suspended Thursday due to unstable debris as the region grapples with the aftermath of what glaciologists describe as a climate-driven disaster.
The collapse of a large chunk of the Birch Glacier, located above Blatten, sent ice, rock, and mud crashing down the mountainside, flattening homes and submerging buildings in brownish sludge, according to video footage and satellite images. The debris also blocked the Lonza River, causing whatever buildings were left standing to be flooded by the backup of the river.
State Councilor Stéphane Ganzer told Radio Télévision Suisse that the disaster obliterated nearly the entire village.
Bethan Davies, a glaciology professor at Newcastle University, described the event to ABC News as a 'cascading disaster.' The glacier had been destabilized since last week when millions of pounds of rock debris fell onto its surface. Warm temperatures on Monday exacerbated the instability, accelerating the collapse.
'This is a marked acceleration,' Davies said. 'Lots of cracks started to form, a sign of the tension in the ice.'
Authorities evacuated about 300 residents and livestock earlier this month after observing increased glacier melt and debris flow, a precaution that likely saved lives. Mathieu Morlighem, a glaciologist at Dartmouth College, told ABC News the collapse was likely caused by thawing permafrost, which acts as 'glue' to stabilize mountain rock.
'What happened to Birch Glacier is what we would expect from rising temperatures in the Alps and elsewhere,' Morlighem said, comparing it to a 2023 landslide in Switzerland's Silvretta Alps but noting Birch Glacier's larger scale due to excessive ice and meltwater.
One resident told Reuters she 'lost everything' in the mudslide, while another said, 'You can't tell that there was ever a settlement there.'
Werner Bellwald, a resident of the nearby hamlet of Ried, said the landslide wiped out his 1654-built generational family home.
The Cantonal Police of Valais halted search efforts for the missing man Thursday afternoon, citing falling debris. Swiss President Karin Keller-Sutter is scheduled to visit the area on Friday.
Glaciologists link the disaster to climate change, which has accelerated glacier retreat in Switzerland. The country, home to Europe's most glaciers, lost 4% of its glacier volume in 2023, following a record 6% in 2022, The Washington Post reported.
Average temperatures in the Swiss Alps have risen 3 degrees Celsius since the 1970s, said Daniel Farinotti, a glaciologist at ETH Zurich, who warned in March, 'Switzerland's glaciers could vanish completely by 2100.'
A 2024 International Cryosphere Climate Initiative report predicts one-third of European Alps glaciers will disappear by 2050, even without further warming.
Davies noted that warming climates increase mountain landslides by melting permafrost and altering freeze-thaw cycles. Sridhar Anandakrishnan, a glaciologist at Pennsylvania State University, told ABC News that glacial degradation can also form unstable lakes, as seen in the Himalayas and Andes.
The Blatten disaster underscores the growing risks to Alpine communities. Glacierologists are urging further study of climate-driven glacier instability to prevent future catastrophes.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bachem Mourns the Loss of Company Founder Dr. H.C. Peter Grogg
Bachem Mourns the Loss of Company Founder Dr. H.C. Peter Grogg

Yahoo

timean hour ago

  • Yahoo

Bachem Mourns the Loss of Company Founder Dr. H.C. Peter Grogg

Bubendorf, Switzerland--(Newsfile Corp. - June 3, 2025) - The founder and honorary chairman of Bachem (SIX: BANB) Peter Grogg, passed away on Monday, June 2, 2025, at the age of 83. Peter Grogg founded Bachem in 1971 and built the company from a two-person operation into the global market leader for the chemical synthesis of peptides. Peter Grogg was CEO of the company for over 30 years until 2002 and Chairman of the Board of Directors of Bachem Holding AG until 2012. His daughter Nicole Grogg Hötzer has served as Vice-Chairwoman of the Board since 2011. For his achievements and merits in the field of peptides, Peter Grogg was awarded an honorary doctorate by the University of Basel. Kuno Sommer, Chairman of the Board of Directors of Bachem: "With Peter Grogg, we have lost a great entrepreneur. His drive and values made Bachem an internationally successful company and have left a lasting mark on it. In doing so, he has written a chapter of Swiss economic history. On behalf of the Board of Directors, the Executive Committee, and all employees of Bachem, I would like to express our deepest condolences to his wife, his two children, and their families." About Bachem Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with its headquarters in Switzerland and sites in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see For more information: Media Dr. Daniel Grotzky Head Group Communications Tel.: +41 58 595 2021 Email: media@ Investors Barbora Blaha Head Investor Relations Tel.: +41 58 595 0573Email: ir@ This publication may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Bachem Holding AG and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. Bachem Holding AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or developments. To view the source version of this press release, please visit Sign in to access your portfolio

College student discovers mysterious fungus that eluded LSD's inventor
College student discovers mysterious fungus that eluded LSD's inventor

Yahoo

time2 hours ago

  • Yahoo

College student discovers mysterious fungus that eluded LSD's inventor

An undergraduate student at West Virginia University (WVU) recently discovered a mystery fungus that has eluded mycologists for decades. The fungus produces similar effects to the semisynthetic hallucinogenic compound lysergic acid diethylamide–aka LSD. Despite its recreational use, LSD in the right dose can be used to treat addiction, depression, and post-traumatic stress disorder (PTSD). This new species of fungus, named Periglandula clandestina, could share some similar therapeutic benefits. It is described in a study recently published in the journal Mycologia. Periglandula clandestina was discovered by WVU junior and environmental microbiology major Corinne Hazel. She found the species growing on morning glory plants (family Convolvulaceae) while working in the lab with WVU mycologist Daniel Panaccione. Hazel was initially studying how morning glories disperse protective chemicals called ergot alkaloids through their roots. These chemicals are made exclusively by fungi and they are often found growing on grains. Morning glories live in symbiosis with the fungi that produce the same ergot alkaloids. While studying the alkaloids' dispersal on the morning glories in the lab, Hazel saw evidence of a fungus. [ Related: Lion's mane mushroom shows promise in boosting brain cell growth. ] 'We had a ton of plants lying around and they had these tiny little seed coats,' Hazel said in a statement. 'We noticed a little bit of fuzz in the seed coat. That was our fungus.' She and the team at the lab prepared a DNA sample from the suspected fungus and sent it away for genome sequencing to learn more. The sequencing confirmed that this was, in fact, a new species and the sequence is now in a gene bank with Hazel's name on it. 'Sequencing a genome is a significant thing,' Panaccione said in a statement. 'It's amazing for a student.' These same ergot alkaloids were modified by Swiss chemist Albert Hofmann when he invented LSD in the late 1930s. Hoffman hypothesized that a fungus in morning glories would produce alkaloids similar to those in LSD, but the exact species remained a mystery until now. 'Morning glories contain high concentrations of similar lysergic acid derivatives that give them their psychedelic activities,' Panaccione said. 'This inspired Hofmann and others to investigate morning glories for the presence of a hidden fungus related to the ergot fungus that might be the source of these chemicals. They found very similar chemicals, but they could never find the fungus itself.' Ergot alkaloids can be poisonous to humans and livestock and can have unwanted side effects, when used in the incorrect dose. However, some clinicians do use them to treat migraines, dementia, uterine hemorrhaging, and Parkinson's disease. According to the team, the newly discovered Periglandula clandestina is highly efficient at making ergot alkaloids in large quantities, which could make it useful in future pharmaceuticals. [ Related: A hunk of cheese is a perfect playground for fungal antibiotics. ] 'Many things are toxic. But if you administer them in the right dosage or modify them, they can be useful pharmaceuticals,' Panaccione explains. 'By studying them, we may be able to figure out ways to bypass the side effects. These are big issues for medicine and agriculture.' Matt Kasson, a WVU mycologist who was not involved in the study, tells Popular Science, 'Many fungi live in close association with their hosts and can't be easily cultured in vitro. As such, the successful cultivation of these fungi is a huge step forward for understanding their biology.' The name Periglandula clandestina is an homage to just how well it has eluded scientists for nearly a century. 'I think that's the perfect name,' Panaccione said. 'And I love that we did this project together. Corinne [Hazel] has a ton of talent. It's about students recognizing the opportunities, seizing them and having the skill and the brain power to bring this work to fruition.' Going forward, Hazel is studying the most effective ways to culture this slow-growing fungus. She is also interested in whether other morning glory species may also have ergot alkaloids from a fungal symbiote that are still waiting to be discovered. 'I'm lucky to have stumbled into this opportunity,' Hazel said. 'People have been looking for this fungus for years, and one day, I look in the right place, and there it is. I'm very proud of the work that I've done at WVU.'

Joe Biden Reveals How He's Fighting Prostate Cancer and Why He's 'Optimistic' He'll Beat the Disease
Joe Biden Reveals How He's Fighting Prostate Cancer and Why He's 'Optimistic' He'll Beat the Disease

Yahoo

time3 hours ago

  • Yahoo

Joe Biden Reveals How He's Fighting Prostate Cancer and Why He's 'Optimistic' He'll Beat the Disease

Former President Joe Biden has said he is 'optimistic' and "feeling good" about his cancer treatment after announcing his prostate cancer diagnosis in May Biden spoke about his cancer treatment for the first time as he attended a Memorial Day service in Delaware on May 30 'The expectation is we're going to be able to beat this,' Biden told reporters, according to CNNFormer President Joe Biden says he is feeling 'optimistic' since beginning his treatment for prostate cancer. Biden discussed his treatment for the first time publicly since announcing his prostate cancer diagnosis as he attended a Memorial Day service in New Castle, Del., on Friday, May 30. 'Well, the prognosis is good, you know, we're working on everything, it's moving along. I feel good. All the folks are optimistic,' Biden told reporters after speaking at the service in footage captured by ABC News. According to CNN, Biden shared that his treatment consists of him taking a daily pill over the next six weeks before starting another pill. The 82-year-old also said he is being treated by a 'leading surgeon who was diagnosed with the same type of cancer three decades ago,' per the outlet. 'The expectation is we're going to be able to beat this,' said Biden, per CNN. 'It's not in any organ, it's in — my bones are strong, it hadn't penetrated. So, I'm feeling good.' On May 18, Biden released a statement announcing that he had been diagnosed with 'aggressive' prostate cancer that has metastasized to his bones, after 'experiencing increasing urinary symptoms.' The cancer is characterized by a Gleason score of 9 (Grade Group 5),' which 'represents a more aggressive form of the disease,' according to the statement. Biden shared at the time that 'the cancer appears to be hormone-sensitive, which allows for effective management.' During his speech at the Memorial Day service in Delaware on Friday, Biden emotionally acknowledged his late son, former Delaware attorney general Beau Biden, following his passing from glioblastoma in 2015. 'I know for many of you, Memorial Day, like for us, is deeply personal. For the Bidens, this day is the 10th anniversary of the loss of my son Beau, who spent a year in Iraq. And to be honest, it's a hard day,' Biden said, per CNN. 'Being with all of you, quite frankly, makes things a little bit easier. It really does. So, thank you for allowing me to grieve with you.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer​​, from celebrity news to compelling human interest stories. Biden attended the service with Beau's son, Robert 'Hunter' Biden II, 18, according to CNN. The Biden family marked the 10th anniversary of Beau's death at a private mass together that same morning, the outlet reported. The politician's appearance with his family at the service comes after he attended his grandson Hunter's graduation from Salisbury School in Connecticut on May 23. Read the original article on People

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store